170 related articles for article (PubMed ID: 37848865)
1. Effectiveness of a hysteroscopic tissue removal system device for hysteroscopic myomectomy on patients' quality of life: a randomized clinical trial.
Tam T; Juarez L
BMC Womens Health; 2023 Oct; 23(1):541. PubMed ID: 37848865
[TBL] [Abstract][Full Text] [Related]
2. Uterine-Artery Embolization or Myomectomy for Uterine Fibroids.
Manyonda I; Belli AM; Lumsden MA; Moss J; McKinnon W; Middleton LJ; Cheed V; Wu O; Sirkeci F; Daniels JP; McPherson K;
N Engl J Med; 2020 Jul; 383(5):440-451. PubMed ID: 32726530
[TBL] [Abstract][Full Text] [Related]
3. The management of uterine leiomyomas.
Vilos GA; Allaire C; Laberge PY; Leyland N;
J Obstet Gynaecol Can; 2015 Feb; 37(2):157-178. PubMed ID: 25767949
[TBL] [Abstract][Full Text] [Related]
4. Short-term quality of life after myomectomy for uterine fibroids from the COMPARE-UF Fibroid Registry.
Laughlin-Tommaso SK; Lu D; Thomas L; Diamond MP; Wallace K; Wegienka G; Vines AI; Anchan RM; Wang T; Maxwell GL; Jacoby V; Marsh EE; Spies JB; Nicholson WK; Stewart EA; Myers ER
Am J Obstet Gynecol; 2020 Apr; 222(4):345.e1-345.e22. PubMed ID: 31678093
[TBL] [Abstract][Full Text] [Related]
5. Long-term health-related quality of life and symptom severity following hysterectomy, myomectomy, or uterine artery embolization for the treatment of symptomatic uterine fibroids.
Anchan RM; Spies JB; Zhang S; Wojdyla D; Bortoletto P; Terry K; Disler E; Milne A; Gargiulo A; Petrozza J; Brook O; Srouji S; Morton CC; Greenberg J; Wegienka G; Stewart EA; Nicholson WK; Thomas L; Venable S; Laughlin-Tommaso S; Diamond MP; Maxwell GL; Marsh EE; Myers ER; Vines AI; Wise LA; Wallace K; Jacoby VL
Am J Obstet Gynecol; 2023 Sep; 229(3):275.e1-275.e17. PubMed ID: 37244458
[TBL] [Abstract][Full Text] [Related]
6. Hysteroscopic myomectomy for submucosal type 2 fibroids with cold enucleation technique and complete fibroid extraction using a double-lumen intracervical cannula.
Osorio W; Posada N; Cano J; Tamayo S; Giraldo J
Fertil Steril; 2021 Feb; 115(2):522-524. PubMed ID: 33272627
[TBL] [Abstract][Full Text] [Related]
7. Comparative effectiveness of hysterectomy versus myomectomy on one-year health-related quality of life in women with uterine fibroids.
Wallace K; Zhang S; Thomas L; Stewart EA; Nicholson WK; Wegienka GR; Wise LA; Laughlin-Tommaso SK; Diamond MP; Marsh EE; Jacoby VL; Anchan RM; Venable S; Larry GM; Lytle B; Wang T; Myers ER
Fertil Steril; 2020 Mar; 113(3):618-626. PubMed ID: 32192594
[TBL] [Abstract][Full Text] [Related]
8. Validation of the UFS-QOL-hysterectomy questionnaire: modifying an existing measure for comparative effectiveness research.
Coyne KS; Margolis MK; Murphy J; Spies J
Value Health; 2012; 15(5):674-9. PubMed ID: 22867776
[TBL] [Abstract][Full Text] [Related]
9. Uterine artery embolisation versus myomectomy for premenopausal women with uterine fibroids wishing to avoid hysterectomy: the FEMME RCT.
Daniels J; Middleton LJ; Cheed V; McKinnon W; Rana D; Sirkeci F; Manyonda I; Belli AM; Lumsden MA; Moss J; Wu O; McPherson K
Health Technol Assess; 2022 Apr; 26(22):1-74. PubMed ID: 35435818
[TBL] [Abstract][Full Text] [Related]
10. Selective progesterone receptor modulators (SPRMs) for uterine fibroids.
Murji A; Whitaker L; Chow TL; Sobel ML
Cochrane Database Syst Rev; 2017 Apr; 4(4):CD010770. PubMed ID: 28444736
[TBL] [Abstract][Full Text] [Related]
11. The responsiveness of the uterine fibroid symptom and health-related quality of life questionnaire (UFS-QOL).
Harding G; Coyne KS; Thompson CL; Spies JB
Health Qual Life Outcomes; 2008 Nov; 6():99. PubMed ID: 19014505
[TBL] [Abstract][Full Text] [Related]
12. Procedural sedation and analgesia versus general anesthesia for hysteroscopic myomectomy (PROSECCO trial): A multicenter randomized controlled trial.
van der Meulen JF; Bongers MY; van der Zee LG; Leemans JC; Duijnhoven RG; de Leeuw RA; Overdijk LE; Radder CM; van der Voet LF; Smeets NAC; van Vliet HAAM; Hehenkamp WJK; Manger AP; Lim AC; Peters LW; Horree N; Briët JM; van der Steeg JW; Coppus SFPJ; Kok HS
PLoS Med; 2023 Dec; 20(12):e1004323. PubMed ID: 38153958
[TBL] [Abstract][Full Text] [Related]
13. The Impact of Fertility Goals on Long-term Quality of Life in Reproductive-aged Women Who Underwent Myomectomy versus Hysterectomy for Uterine Fibroids.
Frisch EH; Mitchell J; Yao M; Llarena N; Omosigho UR; DeAngelo L; Arakelian M; Bradley L; Falcone T
J Minim Invasive Gynecol; 2023 Aug; 30(8):642-651. PubMed ID: 37044261
[TBL] [Abstract][Full Text] [Related]
14. The management of uterine fibroids in women with otherwise unexplained infertility.
Carranza-Mamane B; Havelock J; Hemmings R; ;
J Obstet Gynaecol Can; 2015 Mar; 37(3):277-285. PubMed ID: 26001875
[TBL] [Abstract][Full Text] [Related]
15. Twelve-month outcomes for patients undergoing hysteroscopic morcellation of uterine polyps and myomas in an office or ambulatory surgical center.
Rubino RJ; Lukes AS
J Minim Invasive Gynecol; 2015 Feb; 22(2):285-90. PubMed ID: 25446547
[TBL] [Abstract][Full Text] [Related]
16. A randomised trial of treating fibroids with either embolisation or myomectomy to measure the effect on quality of life among women wishing to avoid hysterectomy (the FEMME study): study protocol for a randomised controlled trial.
McPherson K; Manyonda I; Lumsden MA; Belli AM; Moss J; Wu O; Middleton L; Daniels J
Trials; 2014 Nov; 15():468. PubMed ID: 25432688
[TBL] [Abstract][Full Text] [Related]
17. Transrectal ultrasound-guided hysteroscopic myomectomy of submucosal myomas with a varying degree of myometrial penetration.
Ludwin A; Ludwin I; Pityński K; Basta P; Basta A; Banas T; Jach R; Wiecheć M; Grabowska R; Stangel-Wójcikiewicz K; Milewicz T; Nocuń A
J Minim Invasive Gynecol; 2013; 20(5):672-85. PubMed ID: 23850363
[TBL] [Abstract][Full Text] [Related]
18. Effects on heavy menstrual bleeding and pregnancy of uterine artery embolization (UAE) or myomectomy for women with uterine fibroids wishing to avoid hysterectomy: The FEMME randomized controlled trial.
Sirkeci F; Moss J; Belli AM; McPherson K; Daniels J; Manyonda I; Middleton L; Cheed V; Wu O; Lumsden MA;
Int J Gynaecol Obstet; 2023 Feb; 160(2):492-501. PubMed ID: 36511801
[TBL] [Abstract][Full Text] [Related]
19. Comparison of Focused Ultrasound Surgery and Hysteroscopic Resection for Treatment of Submucosal Uterine Fibroids (FIGO Type 2).
Hu L; Zhao JS; Xing C; Xue XL; Sun XL; Dang RF; Chen WZ; Wang ZB; Chen JY
Ultrasound Med Biol; 2020 Jul; 46(7):1677-1685. PubMed ID: 32359807
[TBL] [Abstract][Full Text] [Related]
20. Validation of the 4 week recall version of the Uterine Fibroid Symptom and Health-related Quality of Life (UFS-QOL) Questionnaire.
Coyne KS; Soliman AM; Margolis MK; Thompson CL; Chwalisz K
Curr Med Res Opin; 2017 Feb; 33(2):193-200. PubMed ID: 27733082
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
